NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies under the Physician Fee Schedule […]
Letters + Comments
NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the CY 2025 OPPS proposed rule
NHC Comments on Centers for Medicare & Medicaid Services (CMS) in response to the CY 2025 OPPS proposed rule (PDF) September 9, 2024 Chiquita Brooks-LaSure Administrator Centers for Medicare & […]
NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms
NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) Information Collection […]
NHC Comments on Framework for Discussion on Reforming the NIH
NHC Comments on Framework for Discussion on Reforming the NIH (PDF) August 16, 2024 The Honorable Cathy McMorris Rodgers Chair Committee on Energy and Commerce U.S. House of Representatives Washington, […]
NHC Comments on Request for Information (RFI) on the future of 21st Century Cures 2.0 legislation
NHC Comments on Request for Information (RFI) on the future of 21st Century Cures 2.0 legislation (PDF) August 2, 2024 The Honorable Diana DeGette […]
NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning
NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning (PDF) July […]
NHC Comments on the Federal Evidence Agenda on Disability Equity
NHC Comments on the Federal Evidence Agenda on Disability Equity (PDF) July 15, 2024 Office of Science and Technology Executive Office of the President 1650 Pennsylvania Avenue NW Washington, DC […]
NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027
NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation […]
NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents (CMS-10882) – IRA
NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents (CMS-10882) – IRA (PDF) June 27, 2024 Chiquita Brooks-LaSure Administrator […]
NHC Comments on Response to the Medicare Program; Request for Information on Medicare Advantage Data
NHC Comments on Response to the Medicare Program; Request for Information on Medicare Advantage Data (PDF) May 29, 2024 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of […]